These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18523453)

  • 21. Association of syndromic mental retardation and autism with 22q11.2 duplication.
    Lo-Castro A; Galasso C; Cerminara C; El-Malhany N; Benedetti S; Nardone AM; Curatolo P
    Neuropediatrics; 2009 Jun; 40(3):137-40. PubMed ID: 20020400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 5.3Mb deletion in chromosome 18q12.3 as the smallest region of overlap in two patients with expressive speech delay.
    Bouquillon S; Andrieux J; Landais E; Duban-Bedu B; Boidein F; Lenne B; Vallée L; Leal T; Doco-Fenzy M; Delobel B
    Eur J Med Genet; 2011; 54(2):194-7. PubMed ID: 21145994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 372 kb microdeletion in 18q12.3 causing SETBP1 haploinsufficiency associated with mild mental retardation and expressive speech impairment.
    Marseglia G; Scordo MR; Pescucci C; Nannetti G; Biagini E; Scandurra V; Gerundino F; Magi A; Benelli M; Torricelli F
    Eur J Med Genet; 2012 Mar; 55(3):216-21. PubMed ID: 22333924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cryptic duplication 22q13.31 to qter leads to a distinct phenotype with mental retardation, microcephaly and mild facial dysmorphism.
    Peeters H; Vermeesch J; Fryns JP
    Genet Couns; 2008; 19(4):365-71. PubMed ID: 19239079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proximal 6q interstitial deletion without severe mental retardation.
    Myers SM; Challman TD
    Genet Couns; 2005; 16(3):269-76. PubMed ID: 16259324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 22q13.3 deletion syndrome: clinical and molecular analysis using array CGH.
    Dhar SU; del Gaudio D; German JR; Peters SU; Ou Z; Bader PI; Berg JS; Blazo M; Brown CW; Graham BH; Grebe TA; Lalani S; Irons M; Sparagana S; Williams M; Phillips JA; Beaudet AL; Stankiewicz P; Patel A; Cheung SW; Sahoo T
    Am J Med Genet A; 2010 Mar; 152A(3):573-81. PubMed ID: 20186804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome.
    Sarasua SM; Dwivedi A; Boccuto L; Chen CF; Sharp JL; Rollins JD; Collins JS; Rogers RC; Phelan K; DuPont BR
    Genet Med; 2014 Apr; 16(4):318-28. PubMed ID: 24136618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 6p subtelomere deletion syndrome.
    DeScipio C
    Am J Med Genet C Semin Med Genet; 2007 Nov; 145C(4):377-82. PubMed ID: 17918735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosomal deletion unmasking a recessive disease: 22q13 deletion syndrome and metachromatic leukodystrophy.
    Bisgaard AM; Kirchhoff M; Nielsen JE; Kibaek M; Lund A; Schwartz M; Christensen E
    Clin Genet; 2009 Feb; 75(2):175-9. PubMed ID: 19054018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multigene deletions on chromosome 20q13.13-q13.2 including SALL4 result in an expanded phenotype of Okihiro syndrome plus developmental delay.
    Borozdin W; Graham JM; Böhm D; Bamshad MJ; Spranger S; Burke L; Leipoldt M; Kohlhase J
    Hum Mutat; 2007 Aug; 28(8):830. PubMed ID: 17623483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome.
    Bonaglia MC; Giorda R; Beri S; De Agostini C; Novara F; Fichera M; Grillo L; Galesi O; Vetro A; Ciccone R; Bonati MT; Giglio S; Guerrini R; Osimani S; Marelli S; Zucca C; Grasso R; Borgatti R; Mani E; Motta C; Molteni M; Romano C; Greco D; Reitano S; Baroncini A; Lapi E; Cecconi A; Arrigo G; Patricelli MG; Pantaleoni C; D'Arrigo S; Riva D; Sciacca F; Dalla Bernardina B; Zoccante L; Darra F; Termine C; Maserati E; Bigoni S; Priolo E; Bottani A; Gimelli S; Bena F; Brusco A; di Gregorio E; Bagnasco I; Giussani U; Nitsch L; Politi P; Martinez-Frias ML; Martínez-Fernández ML; Martínez Guardia N; Bremer A; Anderlid BM; Zuffardi O
    PLoS Genet; 2011 Jul; 7(7):e1002173. PubMed ID: 21779178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.
    Kleefstra T; van Zelst-Stams WA; Nillesen WM; Cormier-Daire V; Houge G; Foulds N; van Dooren M; Willemsen MH; Pfundt R; Turner A; Wilson M; McGaughran J; Rauch A; Zenker M; Adam MP; Innes M; Davies C; López AG; Casalone R; Weber A; Brueton LA; Navarro AD; Bralo MP; Venselaar H; Stegmann SP; Yntema HG; van Bokhoven H; Brunner HG
    J Med Genet; 2009 Sep; 46(9):598-606. PubMed ID: 19264732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome.
    Pasini A; D'Agati E; Casarelli L; Curatolo P
    Brain Dev; 2010 May; 32(5):425-7. PubMed ID: 19428206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced expression by SETBP1 haploinsufficiency causes developmental and expressive language delay indicating a phenotype distinct from Schinzel-Giedion syndrome.
    Filges I; Shimojima K; Okamoto N; Röthlisberger B; Weber P; Huber AR; Nishizawa T; Datta AN; Miny P; Yamamoto T
    J Med Genet; 2011 Feb; 48(2):117-22. PubMed ID: 21037274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fraternal twins with Phelan-McDermid syndrome not involving the SHANK3 gene: case report and literature review.
    Li S; Xi KW; Liu T; Zhang Y; Zhang M; Zeng LD; Li J
    BMC Med Genomics; 2020 Oct; 13(1):146. PubMed ID: 33023580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interstitial deletion of a proximal 3p: a clinically recognisable syndrome.
    Lalli C; Galasso C; Lo Castro A; Nardone AM; Di Paolo A; Curatolo P
    Brain Dev; 2007 Jun; 29(5):312-6. PubMed ID: 17125947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome.
    Van der Aa N; Rooms L; Vandeweyer G; van den Ende J; Reyniers E; Fichera M; Romano C; Delle Chiaie B; Mortier G; Menten B; Destrée A; Maystadt I; Männik K; Kurg A; Reimand T; McMullan D; Oley C; Brueton L; Bongers EM; van Bon BW; Pfund R; Jacquemont S; Ferrarini A; Martinet D; Schrander-Stumpel C; Stegmann AP; Frints SG; de Vries BB; Ceulemans B; Kooy RF
    Eur J Med Genet; 2009; 52(2-3):94-100. PubMed ID: 19249392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion.
    Aldinger KA; Kogan J; Kimonis V; Fernandez B; Horn D; Klopocki E; Chung B; Toutain A; Weksberg R; Millen KJ; Barkovich AJ; Dobyns WB
    Am J Med Genet A; 2013 Jan; 161A(1):131-6. PubMed ID: 23225497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome.
    Bonaglia MC; Giorda R; Borgatti R; Felisari G; Gagliardi C; Selicorni A; Zuffardi O
    Am J Hum Genet; 2001 Aug; 69(2):261-8. PubMed ID: 11431708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and genomic evaluation of a Chinese patient with a novel deletion associated with Phelan-McDermid syndrome.
    Lei D; Li S; Banerjee S; Zhang H; Li C; Hou S; Chen D; Yan H; Li H; Peng HH; Liu S; Zhang X; Peng Z; Wang J; Yang H; Huang H; Wu J
    Oncotarget; 2016 Dec; 7(49):80327-80335. PubMed ID: 27741506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.